Sarah Hurst is a 47-year-old freelance journalist based outside of London, where she lives with her mother and 12-year-old daughter. She was in AstraZeneca’s UK trial for the COVID-19 vaccine, and left last week in protest at the company’s announcement that they would work with Russia’s Sputnik vaccine developers. Hurst […]

Jonathan Howard is a neurologist who works at Bellevue Hospital in New York City. During the pandemic, he transitioned to leading a team of healthcare workers tending to COVID-19 patients. Howard says he jumped at the chance to join the AstraZeneca vaccine trial, as he’s had a long-held fascination with […]

The head of the UK’s vaccine taskforce said Tuesday that a “mix and match” trial will combine both Pfizer and AstraZeneca’s COVID-19 vaccines. The trial will test whether combining the two shots works better than administering them individually. AstraZeneca and Oxford’s vaccine has not yet been approved by UK regulators, […]

Millions of Americans may be able to get a coronavirus vaccine before the end of the year, but a substantial portion of the public remains reluctant to get one. Several top economists and two former 2020 presidential candidates are pitching a novel idea: Pay people $US1,000 or more to get […]

Chinese pharmaceutical giant Sinopharm on Tuesday applied to the country’s health regulators to launch its COVID-19 vaccines for public use, based on multiple news reports. However, close to a million people have already been injected with experimental shots since the Chinese government authorised the vaccines for emergency use in July. […]

The UK pharmaceutical company AstraZeneca is likely to run a second global trial to assess its COVID-19 vaccine’s efficacy, its CEO told Bloomberg News on Thursday. AstraZeneca and the University of Oxford announced Monday that preliminary results indicated their two-dose vaccine could be up to 90% effective at preventing COVID-19. […]

AstraZeneca and the University of Oxford are facing criticism over their COVID-19 vaccine trial results after acknowledging a mistake in the vaccine dosage. During the trial, some patients got two full doses of the vaccine, while others had a half-dose in their first shot followed by a full dose in […]

In their COVID-19 vaccine trials, Pfizer and Moderna didn’t monitor participants’ social interactions, risk-taking, or exposure after they were injected with a vaccine or placebo. Volunteers who suspected they’d gotten the vaccine may have been inclined to engage in riskier behaviour. Public-health experts say the risk of getting COVID-19 was […]

Vaccine efficacy measures how well shots prevent disease among vaccinated people in clinical studies, when compared to unvaccinated control groups. Most vaccines are not 100% effective at preventing symptomatic infections. But, if enough people get shots, they can prevent the spread of disease near-perfectly anyway. Visit Business Insider’s homepage for […]

US stocks climbed on Wednesday after Pfizer and BioNTech revealed positive final-analysis data on their coronavirus vaccine. The companies’ candidate was 95% effective at protecting against COVID-19 in trial patients, Pfizer said Wednesday. The firms plan to apply for emergency-use authorization “within days.” The news lifted major indexes and spurred […]

Pfizer and BioNTech jumped on Wednesday trading after final analysis of trial data showed their coronavirus vaccine was 95% effective at protecting against COVID-19. Pfizer gained 4% at intraday highs, while BioNTech climbed as much as 8%. The news also helped drive major indexes higher. The companies now plan to […]

Jenny Hamilton is a 57-year-old former police officer who now works in location security for the film industry and lives in Atlanta. She’s a participant in the Pfizer vaccine trial, which recently announced that it developed the first effective coronavirus vaccine in record time and just filed for emergency authorization […]

Moderna announces it’s ready to submit interim data from its vaccine trial to an independent safety board. Its results are imminent. Dr. Anthony Fauci predicts positive results from Moderna’s coronavirus vaccine trial Markets respond with Moderna’s shares up 5% in premarket. Visit Business Insider’s homepage for more stories. It’s bitter-sweet. […]

The European Union’s drug regulator would approve a COVID-19 vaccine even if it worked in less than half of people, the Wall Street Journal reported. In comparison, the US’s drug regulator, the Food and Drug Administration (FDA), expects a vaccine efficacy rate of at least 50%. The news suggests that […]

AstraZeneca’s COVID-19 vaccine triggers an immune response in elderly people as well as young adults, the drugmaker said Monday. “Immunogenicity responses were similar between older and younger adults,” an AstraZeneca spokesperson said. The vaccine, being developed with the University of Oxford, is one of the world’s leading COVID-19 vaccine candidates. […]

A World Health Organisation study of more than 2,750 COVID-19 patients suggested that the antiviral drug remdesivir had “little or no effect” on survival. The Solidarity trial, which has not yet been peer-reviewed, found remdesivir did not “substantially affect mortality,” reduce the need to ventilate patients, or shorten hospital stays. […]

Investors should sell the dollar, as the chances grow for a clear win by Democrat candidate Joe Biden in the November presidential election and for the development of a successful COVID-19 vaccine, Goldman Sachs said in a note on Friday. Strategists led by Zach Pandl said: “Although there are uncertainties […]